Lingrui Bone Strength Musk Pain Relief Cream

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for external use only. There are no teratogenic effects associated with its use, and no nonteratogenic effects have been mentioned.

Dosage and Administration

The adhesive side of the patch should be applied directly to the affected area. Each patch may be used for a duration of up to 8 hours. It is important to ensure that the patch is securely adhered to the skin to maximize its effectiveness.

Contraindications

Use of this product is contraindicated in the following situations:

Pregnant women should not use this product due to potential risks to fetal development.

Infants and young children are also contraindicated due to safety concerns related to their age and developmental stage.

The product is contraindicated for application on skin ulcers, skin lesions, or infected areas, as these conditions may exacerbate adverse effects or hinder healing.

Individuals with known allergies to this product or its ingredients, including excipients, should avoid use to prevent allergic reactions.

Additionally, those with an allergy to rubber paste are contraindicated from using this product due to the risk of hypersensitivity.

Warnings and Precautions

This product may induce adverse skin reactions, including itching, tingling, rash (such as erythema, papules, and blisters), local edema, and, in rare instances, systemic discomfort. Healthcare professionals should monitor patients for these symptoms and advise them to discontinue use and contact their physician if any of these reactions occur.

Pregnant women, infants, and young children are strictly prohibited from using this product. Additionally, it should not be applied to individuals with skin ulcers, skin lesions, or infected areas. Patients with known allergies to this product or its ingredients, including excipients, as well as those allergic to rubber paste, should also avoid its use.

For patients with diabetes, it is recommended that they consult their healthcare provider regarding the appropriateness of this product and any necessary laboratory tests to ensure safe usage.

Side Effects

Patients using this product may experience a range of adverse reactions. Serious reactions can include itching, tingling, rash (such as erythema, papules, and blisters), local edema, and skin ulceration. In rare instances, patients may also report systemic discomfort.

It is advised that patients discontinue use of the product if they experience any of the following symptoms: itching, tingling, rash (including erythema, papules, and blisters), local edema, or skin ulceration. These reactions warrant immediate attention to ensure patient safety and to mitigate any potential complications.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Lingrui Bone Strength Musk Pain Relief Cream (bone strength musk pain relief cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients, particularly infants and young children, are prohibited from using this product. It is essential to keep this product out of reach of children to prevent accidental ingestion or misuse.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients are prohibited from using this medication due to potential risks to fetal health. The available data indicate that the use of this drug during pregnancy may pose significant risks, and therefore, it is essential for healthcare providers to counsel women of childbearing potential regarding these risks. Women who are pregnant or planning to become pregnant should avoid this medication to prevent any adverse fetal outcomes.

Lactation

Lactating mothers are advised against the use of this medication, as it is prohibited for pregnant women. Additionally, it is not recommended for infants and young children. There is no available data on the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution should be exercised when considering this treatment in lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and treatment protocols tailored to the substance involved in the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

Prohibition of use in pregnant women is indicated due to teratogenic effects associated with this product.

In terms of non-teratogenic effects, the product may elicit symptoms such as itching, tingling, rash (including erythema, papules, and blisters), local edema, and skin ulceration. In rare instances, systemic discomfort may also occur.

No relevant information is available regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse events reported voluntarily or through surveillance programs. The product may cause symptoms including itching, tingling, and rash, which can manifest as erythema, papules, or blisters. Local edema and skin ulceration have also been observed. In rare instances, systemic discomfort has been reported.

Patients are advised to discontinue use if they experience any of the following: itching, tingling, rash (such as erythema, papules, or blisters), local edema, or skin ulceration.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse. It is important for patients with diabetes to consult their healthcare provider regarding the use of this product, as specific considerations may apply to their condition.

Storage and Handling

The product is supplied in a configuration that allows for easy application and disposal. It is essential to store the product at room temperature to maintain its efficacy. To ensure safety, the product should be kept out of reach of children.

Each patch is designed for single use, with a recommended application duration of up to 8 hours. It is important to replace the patch every 24 hours to ensure optimal performance. After opening, the patch must be discarded to prevent any potential contamination or degradation.

Additional Clinical Information

The Lingrui Bone Strengthening Musk Pain Relieving Cream is administered topically and should be replaced every 24 hours. Patients are advised to use one patch for a maximum duration of 8 hours. Clinicians should counsel patients with diabetes to consult their healthcare provider before use. Additionally, it is important to keep this product out of reach of children to ensure safety.

Drug Information (PDF)

This file contains official product information for Lingrui Bone Strength Musk Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)